Autoimmune Diseases
295
80
87
114
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
21 trials with published results (7%)
Research Maturity
114 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
8 terminated out of 295 trials
93.4%
+6.9% vs benchmark
6%
17 trials in Phase 3/4
18%
21 of 114 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 114 completed trials
Clinical Trials (295)
Deciphering the Genetic Architecture of Autoimmune Diseases
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases
FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.
Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases
Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
Personalized Therapies in Inflammatory Complex Disease
Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D
Network to Understand Reproductive Rheumatology Registry
Testimonials and Navigation in Rheumatology